There is 1 paper on nigral R2* in aging research: 1 observational study in people.
1 paper studies it1 finding
“Hydrophilic statin users, however, demonstrated faster clinical progression of non-motor symptoms [MDS-UPDRS-I (β= 4.8, p = 0.010)] and nigral R2* (β= 3.7, p = 0.043).”
- Humans1
Associations
1Hydrophilic statins
upin humans1
1 study
Hydrophilic statins
upin humans1
Hydrophilic statins are associated with nigral R2* in humans (Parkinson's disease; compared with statin non-users) (β= 3.7, p = 0.043).
“Hydrophilic statin users, however, demonstrated faster clinical progression of non-motor symptoms [MDS-UPDRS-I (β= 4.8, p = 0.010)] and nigral R2* (β= 3.7, p = 0.043).”
HumansParkinson's disease; compared with statin non-userssubstantia nigra18 months
Parkinson's Disease Progression and Statins: Hydrophobicity Matters
Journal of Parkinson's disease
Latest
Journal of Parkinson's Disease
Parkinson's Disease Progression and Statins: Hydrophobicity Matters
Cohort study of 125 peopleParkinson's disease